AS, ankylosing spondylitis

Utility and direct costs: ankylosing spondylitis compared with rheumatoid arthritis
S M M Verstappen, J W G Jacobs, D M van der Heijde, Sj van der Linden, C M Verhoef, J W J Bijlsma, A Boonen

Annals of the Rheumatic Diseases Jun 2007, 66 (6) 727-731; DOI: 10.1136/ard.2006.061283
Are there gender differences in severity of ankylosing spondylitis? Results from the PSOAS cohort
Wonuk Lee, John D Reveille, John C Davis, Thomas J Learch, Michael M Ward, Michael H Weisman

Annals of the Rheumatic Diseases May 2007, 66 (5) 633-638; DOI: 10.1136/ard.2006.060293
Immunohistological examination of open sacroiliac biopsies of patients with ankylosing spondylitis: detection of tumour necrosis factor α in two patients with early disease and transforming growth factor β in three more advanced cases
R J François, L Neure, J Sieper, J Braun

Annals of the Rheumatic Diseases Jun 2006, 65 (6) 713-720; DOI: 10.1136/ard.2005.037465
Sexual dimorphism, but not testosterone itself, is responsible for ankylosing enthesitis of the ankle in B10.BR (H-2^k) male mice
J Capkova, P Ivanyi, Z Rehakova

Annals of the Rheumatic Diseases Jan 2006, 65 (1) 130-132; DOI: 10.1136/ard.2005.039800
Double blind, randomised, placebo controlled study of leflunomide in the treatment of active ankylosing spondylitis
J C van Denderen, M van der Paardt, M T Nurmohamed, Y M M A de Ryck, B A C Dijkmans, I E van der Horst-Bruinsma

Annals of the Rheumatic Diseases Dec 2005, 64 (12) 1761-1764; DOI: 10.1136/ard.2005.036491
Very early spondyloarthritis: where the inflammation in the sacroiliac joints starts
M Bollow, K-G A Hermann, T Biedermann, J Sieper, M Schöntube, J Braun

Annals of the Rheumatic Diseases Nov 2005, 64 (11) 1644-1646; DOI: 10.1136/ard.2004.034967
Willingness of patients with ankylosing spondylitis to pay for inpatient treatment is influenced by the treatment environment and expectations of improvement
A Boonen, J L Severens, A van Tubergen, R Landewé, G Bonsel, D van der Heijde, Sj van der Linden

Annals of the Rheumatic Diseases Nov 2005, 64 (11) 1650-1652; DOI: 10.1136/ard.2005.038786
Sustained durability and tolerability of etanercept in ankylosing spondylitis for 96 weeks
J C Davis, D M van der Heijde, J Braun, M Dougados, J Cush, D Clegg, R D Inman, A Kivitz, L Zhou, A Solinger, W Tsuji

Annals of the Rheumatic Diseases Nov 2005, 64 (11) 1557-1562; DOI: 10.1136/ard.2004.035105
Efficacy of cyclo-oxygenase-2 inhibition by etoricoxib and naproxen on the axial manifestations of ankylosing spondylitis in the presence of peripheral arthritis
L Gossec, D van der Heijde, A Melian, D A Krupa, M K James, P F Cavanaugh, A S Reicin, M Dougados

Annals of the Rheumatic Diseases Nov 2005, 64 (11) 1563-1567; DOI: 10.1136/ard.2004.029611
Infliximab in combination with methotrexate in active ankylosing spondylitis: a clinical and imaging study
H Marzo-Ortega, D McGonagle, S Jarrett, G Haugeberg, E Hensor, P O’Connor, A L Tan, P G Conaghan, A Greenstein, P Emery

Annals of the Rheumatic Diseases Nov 2005, 64 (11) 1568-1575; DOI: 10.1136/ard.2004.022582

Main menu

AS, ankylosing spondylitis

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

AS, ankylosing spondylitis

Pages